Evidence map›Paper›PMID 29572832›Full record

ReviewThe Journal of physiology2018

When muscle Ca

Bruno Allard, Clarisse Fuster

Open access · bronzeAbstract readReview
In one paragraph

Review in The Journal of physiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. A novel CACNA1S variant associated with diltiazem-related worsening of hypokalemic periodic paralysis: a case report.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Article
  2. Review
  3. Article
  4. Evaluation of mutant muscle CaThe Journal of general physiology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Bruno AllardInstitut NeuroMyoGene, Université de Lyon, Université Lyon 1, UMR CNRS 5310, Inserm U1217, 43 bd du 11 Novembre 1918, 69622 Villeurbanne, France.ORCID 0000-0002-7131-7828
Clarisse FusterInstitut NeuroMyoGene, Université de Lyon, Université Lyon 1, UMR CNRS 5310, Inserm U1217, 43 bd du 11 Novembre 1918, 69622 Villeurbanne, France.ORCID 0000-0003-2205-1610
Université Claude Bernard Lyon 1 · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients suffering from type 1 hypokalaemic periodic paralysis (HypoPP1) experience attacks of muscle paralysis associated with hypokalaemia. The disease arises from missense mutations in the gene encoding the α1 subunit of the dihydropyridine receptor (DHPR), a protein complex anchored in the tubular membrane of skeletal muscle fibres which controls the release of Ca

Indexed as

Ion Channel GatingAnimalsCalcium ChannelsCations, MonovalentHumansHypokalemic Periodic ParalysisMuscle, SkeletalCalcium ChannelsCations, Monovalentgating porehypokalemic periodic paralysisskeletal musclevoltage-gated Ca2+ channels

Identifiers

PMID29572832
PMCPMC5983135
OpenAlexW2805785941

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.